Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

MEDTRONIC VASCULAR, INC.

US

Last updated September 17, 2026

What MEDTRONIC VASCULAR, INC. makes

The company manufactures non-bioabsorbable soft-tissue mesh anchors, including systems and cassettes for endoscopic or minimally invasive fixation, such as the Heli-FX EndoAnchor System and its thoracic variants. It also produces an introducer sheath with a hydrophilic coating for procedural use.

These devices are regulated under FDA Class II and Class III classifications, with authorisation records in 510(k), PMA, and UDI registries. The company is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Medtronic Vascular, Inc. primarily manufacture?

Medtronic Vascular, Inc. specializes in non-bioabsorbable soft-tissue mesh anchors designed for endoscopic or minimally invasive surgical fixation. Their portfolio includes systems like the Heli-FX EndoAnchor System and its thoracic-specific variants, as well as ancillary components such as cassettes. Additionally, they produce procedural tools like the Sentrant Introducer Sheath with a hydrophilic coating, which reduces friction during insertion.

Where is Medtronic Vascular, Inc. based, and how does that affect its regulatory oversight?

Medtronic Vascular, Inc. is headquartered in the United States, which means its devices fall under the jurisdiction of the U.S. Food and Drug Administration (FDA). The FDA classifies these devices as either Class II or Class III, depending on their risk level and intended use, requiring pre-market authorisation through pathways like 510(k) clearances, Premarket Approvals (PMAs), or Unique Device Identification (UDI) registrations.

Which regulatory registries list Medtronic Vascular, Inc.’s devices, and why?

Medtronic Vascular, Inc.’s devices are listed in the FDA’s 510(k), PMA, and UDI registries. The 510(k) pathway applies to Class II devices deemed substantially equivalent to existing approved products, while Class III devices—often higher-risk—require a Premarket Approval (PMA) to demonstrate safety and effectiveness. The UDI registry ensures traceability and transparency in the supply chain, tracking devices throughout their lifecycle for compliance and recall purposes.

How are Medtronic Vascular, Inc.’s devices classified by the FDA, and what does that mean for their use?

The FDA classifies Medtronic Vascular, Inc.’s devices as either Class II or Class III. Class II devices, like some mesh anchors, typically require performance standards and 510(k) clearance to prove they’re as safe and effective as comparable legacy products. Class III devices, such as certain high-risk fixation systems, require a Premarket Approval (PMA) to demonstrate safety and efficacy through rigorous clinical trials, as they lack a predicate device or pose greater risks.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
3576 Unocal Pl, Santa Rosa, CA, 95403
Website
medtronic.com
LinkedIn
—
Facebook
—
Phone
+1(800)633-8766
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
3001452571
DUNS Number
080009661

Catalogue (509)

Page 4 of 11
DeviceModel / ReferenceRegistriesClassStatus
Medtronic Model 6416 Transvenous Bipolar Temporary Pacing Lead K973360
FDA 510(k)
Class IIActive
Model 1730 Neotrode With Attached Leadwire K901555
FDA 510(k)
Class IIActive
Medtronic Model 4058 Pacing Lead K883743
FDA 510(k)
Class IIIActive
Eclipse+, Model Number 7723 K865048
FDA 510(k)
Class IIActive
Processing System, A2 Image K782047
FDA 510(k)
Class IActive
U-Clip Device, Model Nc65 K062057
FDA 510(k)
Class IIActive
Minimax (tm) Hardshell Venous Res W/Inte Card Filt K911789
FDA 510(k)
Class IIActive
Attain Select 6238tel Guide Catheter Set For Left-Heart Delivery K042194
FDA 510(k)
Class IIActive
Subcupass Tunneling Tool K780579
FDA 510(k)
Class IActive
Medtronic #4951 K812599
FDA 510(k)
Class IIIActive
Medtronic Model 9455 Teletrace Iii Ecg Monit Syst K914974
FDA 510(k)
Class IIActive
Model 5866-34 Lead Adaptor Kit K900627
FDA 510(k)
Class IIActive
Blood Flowmeter System K780302
FDA 510(k)
Class IIActive
Generators, Atrial Inhibited Pulse K780327
FDA 510(k)
Class IIIActive
Madtronic Dlp Arterial Cannulae K991066
FDA 510(k)
Class IIActive
Multi-Programmable Pacemaker & Progrmr. K801584
FDA 510(k)
Class IIIActive
Medtronic Arterial Filter K926413
FDA 510(k)
Class IIActive
Heli-FX EndoAnchor System K182957
FDA 510(k)
Class IIActive
10600 Deflectable Catheter System, Model 10600 K013517
FDA 510(k)
Class IIActive
Peripheral Nerve Stimulation K982902
FDA 510(k)
Class IIActive
Neurological Screening Stimulator M 3623 K780758
FDA 510(k)
Class IIActive
Minix 8340, 8341, 8342 Minix-St 8330, 8331 K884215
FDA 510(k)
Class IIIActive
Alternate Size E-Z-Pace Electrode K862298
FDA 510(k)
Class IIActive
Medtronic Model 7499 Extension K000445
FDA 510(k)
Class IIActive
Medtronic Catheter Access Port Model 8500 K873735
FDA 510(k)
Class IIActive
Modumed Mugx K780368
FDA 510(k)
Class IIActive
Medtronic 3625 Screener System K913442
FDA 510(k)
Class IIActive
Promeon Hydrogel Dressing #45 Nonsterile W/ Mesh K915358
FDA 510(k)
Class IActive
Transvenous, Permanent Tined Target Tip Pacing Leads/Transvenous, Permanent Screw-In Pacing Leads K961679
FDA 510(k)
Class IIIActive
Pulse Generators, Models 5972/5973 K780061
FDA 510(k)
Class IIIActive
Medtronic #3798 Electrode K812418
FDA 510(k)
Class IIActive
Medtronic Model 4016 Bipolar Endocardial Screw-In K850968
FDA 510(k)
Class IIActive
Precision Plus Tuna Office System; Presision Tuna Office System; Provu Tuna System K021804
FDA 510(k)
Class IIActive
Medtens(tm), Model Number 7725 K871722
FDA 510(k)
Class IIActive
Spherical Tip Coronary Ostial Cannula, Model 30011 K034058
FDA 510(k)
Class IIActive
Gt2 Fusion Guide Wire, Model Ntlhlj180, Ntlhls180, Ntlhlj300, Ntlhls300 K001969
FDA 510(k)
Class IIActive
Mod Target/Tips # 4011, 4012, 4511, 4512, 6912, 4016 K854582
FDA 510(k)
Class IIIActive
Medtronic Model 6404 K851948
FDA 510(k)
Class IIActive
Medtronic Models 8432/8433/8434 - Pacemaker Pulse K844958
FDA 510(k)
Class IIIActive
Model 6971 W/ Dbs Wire K790988
FDA 510(k)
Class IIIActive
Medtronic Model 5407s, 5807s & 5410s Surg Cables K914460
FDA 510(k)
Class IIActive
Respond Quadriflex #3129 Single Channel K823279
FDA 510(k)
Class IIActive
Temporary Screening Lead/ Catheter Kit K934939
FDA 510(k)
Class IIActive
5F Launcher Guide Catheter, 6F Launcher Guide Catheter, 7F Launcher Guide Catheter, 8F Launcher Guide Catheter K230156
FDA 510(k)
Class IIActive
Medtronic A-V Pacing System Analyzer K812262
FDA 510(k)
Class IIActive
Cardioblate Surgical Ablation Pen, Model 60811c; Cardioblate Surgical Ablation Generator, Model 60880 K013392
FDA 510(k)
Class IIActive
Attain Lds 6216a Left-Heart Delivery System, Model 6216a K021587
FDA 510(k)
Class IIActive
Modified Medtronic Classix Model 8438 Pulse Gene. K901535
FDA 510(k)
Class IIIActive
Model 2331t Patient Programmer K880738
FDA 510(k)
Class IIIActive
Medtronic Model 2409 K812580
FDA 510(k)
Class IIIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (100)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Medtronic Vascular, Inc. has 234 recall records spanning from June 8, 2004, to March 23, 2022, with statuses recorded as open, classified, or terminated. The reasons cited include mechanical failures such as detachment of spindle components, radiopaque marker bonds, or taper tips during stent graft deployment; labeling errors such as incorrect usable lengths, master labels, and stentstop assemblies; sterility concerns due to compromised package integrity; and manufacturing defects like retained manufacturing materials in embolization systems. Some records reference procedural complications, such as difficulty flushing delivery systems or potential endoleaks and stent fractures.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Mar 23, 2022Z-1043-2022—open, classified

Packaging for Balloon Catheters may be damaged resulting in loss of sterility.

Mar 23, 2022Z-1042-2022—open, classified

Packaging for Balloon Catheters may be damaged resulting in loss of sterility.

Dec 21, 2021Z-0657-2022—open, classified

Stent Graft Systems built with specific batches of taper tip assemblies have the potential for the taper tip to detach from the delivery system. Detachment of the taper tip during the implant procedure may lead to a secondary intervention to attempt to remove the taper tip, either by endovascular retrieval or surgical conversion. There is also potential that the taper tip is intentionally left behind in the patient, at the physician's discretion, if not easily removable.

Oct 15, 2021Z-0291-2022—open, classified

Due to, during stent graft deployment, the spindle may detach from the distal end of the spindle hypotube.

Oct 15, 2021Z-0292-2022—open, classified

Due to, during stent graft deployment, the spindle may detach from the distal end of the spindle hypotube.

Oct 15, 2021Z-0290-2022—open, classified

During stent graft deployment, the spindle may detach from the distal end of the spindle hypotube

Jun 7, 2021Z-2135-2021—open, classified

During stent graft deployment, the radiopaque (RO) marker bond detached from the distal end of the graft cover.

Jun 7, 2021Z-2136-2021—open, classified

During product complaint investigation, it was determined that during stent graft deployment, the radiopaque (RO) marker bond detached from the distal end of the graft cover.

May 4, 2021Z-1860-2021—terminated

The component part numbers intended for shipment to a third-party, where they are further processed into kits and sterilized were instead shipped directly to customers.

Apr 28, 2021Z-1976-2021—terminated

Incorrect stentstop assembly (18fr) was used to build the delivery system component of the device. Correct stentstop assembly is 20fr.

Feb 12, 2021Z-1201-2021—open, classified

Due to the presence of type IIIb endoleaks, stent fractures, and stent ring enlargement.

Jan 15, 2021Z-1248-2021—terminated

Sterility may be compromised due to an unsealed pouch

Jan 15, 2021Z-1245-2021—terminated

Sterility may be compromised due to an unsealed pouch

Jan 15, 2021Z-1246-2021—terminated

Sterility may be compromised due to an unsealed pouch

Jan 15, 2021Z-1247-2021—terminated

Sterility may be compromised due to an unsealed pouch

Aug 25, 2020Z-0088-2021—terminated

Subsequent failure of catheters in the field and failed quality testing

Aug 25, 2020Z-0087-2021—terminated

Subsequent failure of catheters in the field and failed quality testing

Aug 25, 2020Z-0089-2021—terminated

Subsequent failure of catheters in the field and failed quality testing

Mar 15, 2019Z-2605-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2644-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2651-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2749-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2698-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2699-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2732-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2643-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2579-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2574-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2709-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2589-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2575-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2674-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2591-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2604-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2603-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2738-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2562-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2750-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2686-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2688-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2621-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2684-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2721-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2744-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2682-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2733-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2656-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2662-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2647-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2630-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2565-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2654-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2649-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2571-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2635-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2576-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2626-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2692-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2611-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2714-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2633-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2578-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2600-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2618-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2583-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2636-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2752-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2596-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2581-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2726-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2632-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2672-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2593-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2568-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2685-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2652-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2671-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2639-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2585-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2680-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2638-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2710-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2719-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2646-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2718-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2564-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2742-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2594-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2664-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2715-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2717-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2736-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2658-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2650-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2592-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2569-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2597-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2634-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2712-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

Mar 15, 2019Z-2747-2019—terminated

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.